foxo4-dri senolytic peptide human trial

foxo4-dri senolytic peptide human trial Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment Peptide Inhibitors Targeting FOXO4-p53 Interactions

Name: foxo4-dri senolytic peptide human trial Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment Peptide Inhibitors Targeting FOXO4-p53 Interactions
Brand: southroadsurgery.com.au
SKU: 67474081064
Price: 24.42 USD
Availability: InStock
Rating: 4.6741 (21 reviews)

Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI FOXO4 p53 Interaction Blocker MedChemExpress FOXO4 DRI UK Senolytic Peptide Research Peptides Lab UK PDF) Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes FOX04 DRI Apollo Peptide Sciences

SKU: 67474081064 · From southroadsurgery.com.au

4.7

USD24.42 USD57.42

Pay in 4 interest-free payments of $6.11 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Description

These quality specifications ensure the reconstitution solvent does not introduce endotoxin, microbial, particulate, or chemical contamination into reconstituted research compound solutions